Neuroendocrine and biologic features of primary tumors and tissue in pulmonary large cell carcinomas

Ann Thorac Surg. 2004 Jun;77(6):1883-90. doi: 10.1016/j.athoracsur.2003.11.047.

Abstract

Background: Because biological behavior in lung tumors with neuroendocrine differentiation is highly dependent on cell death (apoptosis) and angiogenesis, p21(waf1/cip1) and microvessel density have been targeted as potentially useful tumor markers. We sought to validate the importance of p21(waf1/cip1) and microvessel density and study their interrelationship, analyzing clinical factors, subclassifications, and tumor and stromal markers.

Methods: We examined p21(waf1/cip1) and other markers in tissue from 61 patients with surgically excised large cell carcinomas. The amount of tumor staining for p21(waf1/cip1) and microvessel density was evaluated by immunohistochemistry and morphometry. The study outcome was survival time until death from recurrent lung cancer.

Results: Multivariate Cox model analysis demonstrated that after surgical excision, histologic subtypes were significantly related to survival time (p = 0.02), but quantitative staining of the tumor for p21(waf1/cip1) and microvessel density added prognostic information and these variables were more strongly prognostic than histologic subtype (p = 0.00). Cut points at the median staining of 3.5% and 3.0% for p21(waf1/cip1) and microvessel density, respectively, divided patients into two groups with distinctive survival times. Patients with p21(waf1/cip1) staining of more than 3.5% and microvessel density staining of more than 3.0% had a median survival time of 14 months.

Conclusions: Tumor staining for p21(waf1/cip1) and microvessel density in resected large cell carcinomas and certain other types of lung tumors was strongly related to survival. Patients with more than 3.0% staining in their tumors were at high risk of death from lung cancer and may be an appropriate target for prospective studies of adjuvant chemotherapy after surgical resection.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Carcinoma, Large Cell / chemistry
  • Carcinoma, Large Cell / mortality
  • Carcinoma, Large Cell / pathology*
  • Carcinoma, Neuroendocrine / chemistry
  • Carcinoma, Neuroendocrine / mortality
  • Carcinoma, Neuroendocrine / pathology*
  • Cyclin-Dependent Kinase Inhibitor p21
  • Cyclins / analysis
  • Cyclooxygenase 2
  • Female
  • Humans
  • Immunohistochemistry
  • Isoenzymes / analysis
  • Lung Neoplasms / chemistry
  • Lung Neoplasms / mortality
  • Lung Neoplasms / pathology*
  • Male
  • Matrix Metalloproteinase 9 / analysis
  • Membrane Proteins
  • Middle Aged
  • Proportional Hazards Models
  • Prostaglandin-Endoperoxide Synthases / analysis
  • Retrospective Studies
  • Survival Rate
  • Tumor Suppressor Protein p53 / analysis

Substances

  • CDKN1A protein, human
  • Cyclin-Dependent Kinase Inhibitor p21
  • Cyclins
  • Isoenzymes
  • Membrane Proteins
  • Tumor Suppressor Protein p53
  • Cyclooxygenase 2
  • PTGS2 protein, human
  • Prostaglandin-Endoperoxide Synthases
  • Matrix Metalloproteinase 9